GHRL and Alzheimer disease: Similarly, Chen et al. (Chen et al. 2017) documented only a mild reduction in pTau [Ser396] after treatment with liraglutide in 10-month-old 3xTg-AD mice, a trend that was mirrored after treatment with palm11-PrRP31 and Dpr3-ghrelin.